Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H39NO5S |
| Molecular Weight | 489.667 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1\C=C\CC(C)=CC[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C2=CSC(C)=N2
InChI
InChIKey=XAYAKDZVINDZGB-BMVMHAJPSA-N
InChI=1S/C27H39NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h8,10-11,13,15,17,19,22-23,25,29,31H,9,12,14H2,1-7H3/b10-8+,16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1
| Molecular Formula | C27H39NO5S |
| Molecular Weight | 489.667 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review. | 2015 |
|
| Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumors. | 2012-02 |
|
| Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues. | 2007-07 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21874318
The recommended phase II dose is 36 mg/m2.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:18 GMT 2025
by
admin
on
Mon Mar 31 18:02:18 GMT 2025
|
| Record UNII |
82481G197K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000041376
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
DB05903
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
C570748
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
DTXSID00870184
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
6918835
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
C77892
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
82481G197K
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY | |||
|
350493-61-7
Created by
admin on Mon Mar 31 18:02:18 GMT 2025 , Edited by admin on Mon Mar 31 18:02:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|